SPRING BANK PHARMACEUTICALS
Spring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on its proprietary platform technology, the company is developing a pipeline of products representing a new class of pharmaceuticals they call small molecule nucleic acid hybrids with a wide range of applications and multi-billion dollar market potential.
SPRING BANK PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Milford, Massachusetts, United States
Country:
United States
Website Url:
http://www.springbankpharm.com
Total Employee:
11+
Status:
Active
Contact:
(508) 473-5993
Email Addresses:
[email protected]
Total Funding:
26 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online IPv6 Microsoft Azure DNS Pound Sterling Microsoft Japanese Yen Microsoft Azure CPanel
Similar Organizations
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Current Employees Featured
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Spring Bank Pharmaceuticals
Official Site Inspections
http://www.springbankpharm.com
Unable to get host informations!!!
